Catalyst Funds Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,200
Closed -$32K 643
2024
Q3
$32K Buy
+1,200
New +$32K 0.01% 966